Home Study CME Enrollment Form

Home Study CME Enrollment Form

Home Study CME Enrollment Form Program Description and Objectives: The Journal of Urology® Home Study Course is a comprehensive learning activity deve...

102KB Sizes 2 Downloads 43 Views

Home Study CME Enrollment Form Program Description and Objectives: The Journal of Urology® Home Study Course is a comprehensive learning activity developed by a team of educators, academicians and clinicians. After completing this activity, participants will be able to assess their knowledge of urology, demonstrate an increased knowledge base of urology, and apply the increased knowledge to improve the quality of patient care. Program Format: Two volumes of The Journal of Urology® are published annually. Each volume is comprised of 6 issues. Five clinically relevant articles are selected by the editor to be offered for CME in each issue of The Journal. For CME credit, the participant must read the articles and answer 5 related questions on the examination; enroll in the home study program; and submit answers online at www.AUAnet.org/cme. Click on CME Test. Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity. Credit Designation: The American Urological Association designates this educational activity for a maximum of 24.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Completion of each test and a score of 80% or above qualify for 2.00 credits of AMA PRA Category 1 Credits™ with up to a maximum of 24.00 credits annually. Original lessons of The Journal of Urology® created and released: issue month 2009; expires: issue month 2012. Target Audience: This home study program is designed for practicing physicians, Board candidates and/or residents. AUA Disclosure Policy: As a provider accredited by the ACCME, the AUA must insure balance, independence, objectivity and scientific rigor in all its activities. All faculty participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUA must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content

with regard to exposition or conclusion. When unlabeled or unapproved uses of drugs or devices are discussed, these are also indicated. Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses or drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. Evidence-Based Content: As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA. Copyright: © American Urological Association, 2009 System Requirements for Online Test: Windows 98, 2000, XP and above or Mac OS 9 and above. Internet access. AUA Privacy and Confidentiality Policy: http://www.auanet.org/cme/onlineeduconf.cfm Program Enrollment: There are 3 convenient ways to enroll in The Journal of Urology® Home Study Course. ●





Complete the form below and return by MAIL including a check or credit card information Complete the form below and return by FAX including your credit card information Enroll online at www.auanet.org. Select The Journal of Urology®. You will need your AUA identification number, password and credit card to purchase this home study product.

The cost for the home study is $60 per year for 2007 to 2009, which includes volumes 177 to 182. Previous home study volumes may be ordered by calling 1-866-746-4282, ext 3747. Email the AUA Office of Education with any questions at [email protected] or [email protected].

The Journal of Urology® Home Study Course Enrollment Form Volume # $60 subscription cost per year includes online posttest Maximum of 24 AMA PRA Category 1 Credits™ annually Name: Address: City:

State:

( ) Check enclosed for $ Charge to

( ) VISA

Zip:

payable to: American Urological Association Education and Research, Inc.

( ) MasterCard

( ) AMEX

Card Number:

Exp. Date:

Signature: Please mail or fax registration form to:

0022-5347/09/1822-0808/0 THE JOURNAL OF UROLOGY® Copyright © 2009 by AMERICAN UROLOGICAL ASSOCIATION

808

www.jurology.com

American Urological Association Education and Research, Inc. 1000 Corporate Blvd. Linthicum, MD 21090 Telephone: 1-410-689-3934 Fax: 1-410-689-3937

Vol. 182, 808-809, August 2009 Printed in U.S.A. DOI:10.1016/j.juro.2009.05.074

809

CME QUESTIONS FOR AUGUST 2009 ISSUE OF THE JOURNAL OF UROLOGY ® 1.

A METHOD TO IMPROVE PATIENT ACCESS IN UROLOGICAL PRACTICE (vol. 182, pp. 663– 667) The key factor that enables a urology practice to improve access is: a) b) c) d) e)

2.

no show rate stable demand patient mix surgery volume payor mix

RENAL FUNCTION ASSESSMENT IN THE ERA OF CHRONIC KIDNEY DISEASE: RENEWED EMPHASIS ON RENAL FUNCTION CENTERED PATIENT CARE (vol. 182, pp. 435– 444) Which of the following statements is true regarding chronic kidney disease (CKD)? a) b) c) d) e)

3.

the increasing prevalence of CKD in the elderly indicates that CKD is part of the natural aging process a serum creatinine less than 1.4 mg/dl eliminates the possibility of CKD CKD can be diagnosed based on a single estimated glomerular filtration rate less than 60 ml per minute per 1.73 m2 increasing CKD stage has been associated with an increase in morbid cardiovascular events choice of intervention for localized renal malignancy has little impact on development or progression of CKD

DEVELOPMENT AND EXTERNAL VALIDATION OF A HIGHLY ACCURATE NOMOGRAM FOR THE PREDICTION OF PERIOPERATIVE MORTALITY AFTER TRANSURETHRAL RESECTION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA (vol. 182, pp. 626 – 632) For the purpose of written informed consent a 72-year-old man with a Charlson comorbidity index score of 2 who is scheduled for transurethral resection of the prostate should be informed that the average risk of death within 30 days after surgery is approximately how high? a) b) c) d) e)

4.

0.01% 0.3% 0.9% 2.2% 4.1%

CLINICAL OUTCOME AND QUALITY OF LIFE ASSESSMENT IN PATIENTS TREATED WITH PERINEAL URETHROSTOMY FOR ANTERIOR URETHRAL STRICTURE DISEASE (vol. 182, pp. 548 –557) Which of the following conditions is not an indication for staged urethroplasty? a) b) c) d) e)

5.

strictures associated with local adverse conditions such as fistula, abscess, cancer uncomplicated posttraumatic bulbar stricture failed complex urethroplasty complicated, failed hypospadias repair extended penile strictures associated with lichen sclerosus

CHEMOPREVENTION OF PROSTATE CANCER (vol. 182, pp. 499 –508) With improved detection of high grade prostate cancer due to improved sensitivity of prostate specific antigen and prostate biopsy for a man on finasteride, chemoprevention with finasteride is expected to have what effect on the risk of high grade prostate cancer? a) b) c) d) e)

25% increased risk of high grade cancer 10% increased risk of high grade cancer no impact on risk of high grade cancer 5% decreased risk of high grade cancer 27% decreased risk of high grade cancer

Publication date: August 2009 Expiration date: August 2012